Apatinib Treatment for Advanced Esophagus Cancer

NCT03170310 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER_GOV

Sponsor class

Conditions

Advanced Esophagus Cancer

Interventions

DRUG: Apatinib

Sponsor

Henan Cancer Hospital

Collaborators

[object Object]